Get the Stockscreener App
2.39
1.24%
-0.03
Park Ha Biological Technology Co Ltd Stock (BYAH) Forecast
The Park Ha Biological Technology Co Ltd (BYAH) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $39.32, representing a +1,545% increase from the current price of $2.39. The highest analyst price target is $41.95, and the lowest is $36.68.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BYAH Price Target
Average 47.42
(+1,884% Upside)
Is Park Ha Biological Technology Co Ltd (BYAH) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.62 | Neutral |
| STOCH(9,6) | 39.94 | Neutral |
| STOCHRSI(14) | 53.84 | Neutral |
| MACD(12,26) | -0.0929 | Buy |
| ADX(14) | 56.80 | Buy |
| William %R | -63.08 | Neutral |
| CCI(14) | -46.82 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.4225
Sell
|
2.4261
Sell
|
| MA20 |
2.4652
Sell
|
2.4704
Sell
|
| MA50 |
2.6789
Sell
|
3.0869
Sell
|
| MA100 |
4.9535
Sell
|
7.4899
Sell
|
| MA200 |
14.34
Sell
|
24.19
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, BYAH could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on BYAH, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.62 indicates that BYAH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 39.94 indicates that BYAH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 53.84 indicates that BYAH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 56.8 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -46.82 indicates that BYAH is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BYAH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Park Ha Biological Technology Co Ltd financial reports and earnings history, Park Ha Biological Technology Co Ltd (BYAH) stock could reach $425.68 by 2030, $1,642.98 by 2040 and $2,394.32 by 2050. See the projected annual prices until 2050 of the Park Ha Biological Technology Co Ltd stock below:
- Park Ha Biological Technology Co Ltd (BYAH) is expected to reach an average price of $497.84 in 2035, with a high prediction of $579.99 and a low estimate of $499.20. This indicates an $20,730% rise from the last recorded price of $2.39.
- Park Ha Biological Technology Co Ltd (BYAH) stock is projected to chart a bullish course in 2040, with an average price target of $1,555.15, representing an $64,969% surge from its current level. The forecast ranges from a conservative $1,563.83 to a sky-high $1,642.98.
- Our analysts predict Park Ha Biological Technology Co Ltd (BYAH) to jump 28,607% by 2045, soaring from $686.25 to an average price of $686.10, potentially reaching $850.92. While $686.25 is the low estimate, the potential upside is significant.
- Park Ha Biological Technology Co Ltd (BYAH) stock is expected to climb by 2050, reaching an average of $2,220.88, a $92,824% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2,394.32 and $2,222.00, respectively, highlighting the market's uncertainty.
Park Ha Biological Technology Co Ltd Stock (BYAH) Year by Year Forecast
Park Ha Biological Technology Co Ltd Stock (BYAH) Price Forecast for 2026
The predicted value for Park Ha Biological Technology Co Ltd (BYAH) in 2026 is set at an average of $36.17. Estimates vary from a peak of $70.44 to a trough of $1.90, indicating an +1,413% surge from the present price of $2.39.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $49.23 | $36.68 | $41.95 | +1,960% |
| December, 2026 | $53.93 | $55.06 | $52.37 | +2,157% |
Park Ha Biological Technology Co Ltd Stock (BYAH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Park Ha Biological Technology Co Ltd (BYAH) is $85.45, with a high forecast of $168.29 and a low forecast of $2.6105. This indicates an +3,475% increase from the last price of $2.39.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $76.56 | $53.02 | $48.99 | +3,103% |
| February, 2027 | $86.90 | $82.27 | $83.62 | +3,536% |
| March, 2027 | $80.50 | $81.37 | $84.55 | +3,268% |
| April, 2027 | $70.24 | $70.56 | $77.79 | +2,839% |
| May, 2027 | $57.35 | $57.65 | $67.29 | +2,300% |
| June, 2027 | $45.26 | $46.22 | $52.74 | +1,794% |
| July, 2027 | $41.00 | $41.47 | $41.75 | +1,615% |
| August, 2027 | $29.61 | $29.91 | $38.69 | +1,139% |
| September, 2027 | $20.22 | $20.34 | $26.87 | +745.91% |
| October, 2027 | $10.25 | $10.28 | $17.61 | +328.83% |
| November, 2027 | $176.91 | $2.6105 | $131.75 | +7,302% |
| December, 2027 | $181.99 | $173.92 | $168.29 | +7,515% |
Park Ha Biological Technology Co Ltd Stock (BYAH) Price Forecast for 2028
In 2028, Park Ha Biological Technology Co Ltd (BYAH) is projected to reach an average price of $142.90, with a high projection of $278.26 and a low estimate of $7.5359. This indicates an +5,879% rise from the last price of $2.39.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $175.91 | $182.13 | $175.08 | +7,260% |
| February, 2028 | $188.35 | $167.36 | $168.42 | +7,781% |
| March, 2028 | $188.52 | $188.97 | $185.24 | +7,788% |
| April, 2028 | $174.60 | $174.82 | $183.62 | +7,205% |
| May, 2028 | $148.95 | $149.27 | $169.16 | +6,132% |
| June, 2028 | $126.92 | $127.24 | $143.47 | +5,210% |
| July, 2028 | $101.07 | $102.03 | $122.07 | +4,129% |
| August, 2028 | $86.64 | $87.11 | $95.02 | +3,525% |
| September, 2028 | $67.78 | $68.36 | $81.79 | +2,736% |
| October, 2028 | $42.95 | $43.07 | $61.88 | +1,697% |
| November, 2028 | $22.81 | $22.84 | $37.81 | +854.32% |
| December, 2028 | $292.42 | $7.5359 | $278.26 | +12,135% |
Park Ha Biological Technology Co Ltd Stock (BYAH) Price Forecast for 2029
The 2029 price forecast for Park Ha Biological Technology Co Ltd Stock (BYAH) is $171.74 on average, with a high prediction of $308.08 and a low estimate of $35.40. This represents an +7,086% increase from the previous price of $2.39.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $316.69 | $311.17 | $308.08 | +13,151% |
| February, 2029 | $309.96 | $309.19 | $306.26 | +12,869% |
| March, 2029 | $277.82 | $281.70 | $296.32 | +11,524% |
| April, 2029 | $290.13 | $291.25 | $286.85 | +12,040% |
| May, 2029 | $266.04 | $266.26 | $282.70 | +11,031% |
| June, 2029 | $234.99 | $235.55 | $258.06 | +9,732% |
| July, 2029 | $195.46 | $195.78 | $227.35 | +8,078% |
| August, 2029 | $163.32 | $166.88 | $188.06 | +6,734% |
| September, 2029 | $137.85 | $137.99 | $151.53 | +5,668% |
| October, 2029 | $103.24 | $103.82 | $128.75 | +4,220% |
| November, 2029 | $73.03 | $73.09 | $94.80 | +2,955% |
| December, 2029 | $35.37 | $35.40 | $65.35 | +1,380% |
Park Ha Biological Technology Co Ltd Stock (BYAH) Price Forecast for 2030
Park Ha Biological Technology Co Ltd Stock (BYAH) is expected to reach an average price of $230.16 in 2030, with a high forecast of $447.87 and a low forecast of $12.46. This signifies an +9,530% surge from the last price of $2.39.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $439.84 | $12.46 | $425.68 | +18,303% |
| February, 2030 | $441.65 | $448.41 | $447.87 | +18,379% |
| March, 2030 | $435.05 | $436.25 | $438.41 | +18,103% |
| April, 2030 | $392.16 | $396.04 | $424.12 | +16,309% |
| May, 2030 | $398.41 | $399.77 | $390.65 | +16,570% |
| June, 2030 | $367.74 | $367.78 | $388.47 | +15,287% |
| July, 2030 | $316.25 | $316.81 | $356.99 | +13,132% |
| August, 2030 | $273.13 | $275.53 | $306.07 | +11,328% |
| September, 2030 | $221.68 | $225.24 | $261.61 | +9,175% |
| October, 2030 | $186.03 | $186.17 | $207.35 | +7,684% |
| November, 2030 | $149.09 | $149.42 | $174.39 | +6,138% |
| December, 2030 | $98.31 | $98.37 | $135.20 | +4,013% |
15.20%
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):